Edgewise Therapeutics, Inc.EWTXNASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-14.71%
↑ 76% above average
Average (22q)
-60.14%
Historical baseline
Range
High:95.19%
Low:-1309.68%
Volatility
-2336.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -14.71% |
| Q2 2025 | 20.93% |
| Q1 2025 | -2.38% |
| Q4 2024 | -16.67% |
| Q3 2024 | -5.88% |
| Q2 2024 | -3.03% |
| Q1 2024 | 29.79% |
| Q4 2023 | -14.63% |
| Q3 2023 | -20.59% |
| Q2 2023 | -9.68% |
| Q1 2023 | -19.23% |
| Q4 2022 | 18.75% |
| Q3 2022 | 0.00% |
| Q2 2022 | -10.34% |
| Q1 2022 | -11.54% |
| Q4 2021 | 0.00% |
| Q3 2021 | -23.81% |
| Q2 2021 | 95.19% |
| Q1 2021 | -1309.68% |
| Q4 2020 | -72.22% |
| Q3 2020 | 5.26% |
| Q2 2020 | -18.75% |
| Q1 2020 | 0.00% |